Emerging Role of Eosinophils in Resolution of Arthritis
- PMID: 34733292
- PMCID: PMC8558534
- DOI: 10.3389/fimmu.2021.764825
Emerging Role of Eosinophils in Resolution of Arthritis
Abstract
Eosinophils are a minor component of circulating granulocytes, which are classically viewed as end-stage effector cells in host defense against helminth infection and promoting allergic responses. However, a growing body of evidence has emerged showing that eosinophils are versatile leukocytes acting as an orchestrator in the resolution of inflammation. Rheumatoid arthritis (RA) is the most common chronic inflammatory disease characterized by persistent synovitis that hardly resolves spontaneously. Noteworthy, a specific population of eosinophils, that is, regulatory eosinophils (rEos), was identified in the synovium of RA patients, especially in disease remission. Mechanistically, the rEos in the synovium display a unique pro-resolving signature that is distinct from their counterpart in the lung. Herein, we summarize the latest understanding of eosinophils and their emerging role in promoting the resolution of arthritis. This knowledge is crucial to the design of new approaches to rebalancing immune homeostasis in RA, considering that current therapies are centered on inhibiting pro-inflammatory cytokines and mediators rather than fostering the resolution of inflammation.
Keywords: alternatively activated macrophages; eosinophil; innate lymphoid cells; resolution; rheumatoid arthritis.
Copyright © 2021 Qin, Jin, Li and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Regulatory eosinophils induce the resolution of experimental arthritis and appear in remission state of human rheumatoid arthritis.Ann Rheum Dis. 2021 Apr;80(4):451-468. doi: 10.1136/annrheumdis-2020-218902. Epub 2020 Nov 4. Ann Rheum Dis. 2021. PMID: 33148700
-
Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis.Nat Rev Rheumatol. 2019 Jan;15(1):9-17. doi: 10.1038/s41584-018-0109-2. Nat Rev Rheumatol. 2019. PMID: 30341437 Review.
-
Pulmonary Eosinophils at the Center of the Allergic Space-Time Continuum.Front Immunol. 2021 Nov 15;12:772004. doi: 10.3389/fimmu.2021.772004. eCollection 2021. Front Immunol. 2021. PMID: 34868033 Free PMC article. Review.
-
Multiple Biological Aspects of Eosinophils in Host Defense, Eosinophil-Associated Diseases, Immunoregulation, and Homeostasis: Is Their Role Beneficial, Detrimental, Regulator, or Bystander?Biol Pharm Bull. 2020;43(1):20-30. doi: 10.1248/bpb.b19-00892. Biol Pharm Bull. 2020. PMID: 31902927 Review.
-
Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells.Clin Exp Immunol. 2018 Jul;193(1):13-23. doi: 10.1111/cei.13098. Epub 2018 Feb 2. Clin Exp Immunol. 2018. PMID: 29315512 Free PMC article. Review.
Cited by
-
Obesity, Inflammation, and Immune System in Osteoarthritis.Front Immunol. 2022 Jul 4;13:907750. doi: 10.3389/fimmu.2022.907750. eCollection 2022. Front Immunol. 2022. PMID: 35860250 Free PMC article. Review.
-
Insights Into the Concept of Rheumatoid Arthritis Flare.Front Med (Lausanne). 2022 Mar 17;9:852220. doi: 10.3389/fmed.2022.852220. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35372374 Free PMC article. Review.
-
Revealing the mechanism and efficacy of natural products on treating the asthma: Current insights from traditional medicine to modern drug discovery.Heliyon. 2024 May 28;10(11):e32008. doi: 10.1016/j.heliyon.2024.e32008. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38882318 Free PMC article. Review.
-
Th2 Cytokines (Interleukin-5 and -9) Polymorphism Affects the Response to Anti-TNF Treatment in Polish Patients with Ankylosing Spondylitis.Int J Mol Sci. 2022 Oct 29;23(21):13177. doi: 10.3390/ijms232113177. Int J Mol Sci. 2022. PMID: 36361964 Free PMC article.
-
Causal association between genetically predicted circulating immune cell counts and frailty: a two-sample Mendelian randomization study.Front Immunol. 2024 Jan 23;15:1336498. doi: 10.3389/fimmu.2024.1336498. eCollection 2024. Front Immunol. 2024. PMID: 38322263 Free PMC article.
References
-
- Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, et al. . Efficacy of Pharmacological Treatment in Rheumatoid Arthritis: A Systematic Literature Research Informing the 2019 Update of the EULAR Recommendations for Management of Rheumatoid Arthritis. Ann Rheum Dis (2020) 79(6):744–59. doi: 10.1136/annrheumdis-2019-216656 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical